Acg Wealth Eli Lilly & CO Transaction History

Acg Wealth

$437 Million
Q3 2022

A detailed history of Acg Wealth transactions in Eli Lilly & CO stock. As of the latest transaction made, Acg Wealth holds 2,782 shares of LLY stock, worth $2.08 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

2,782

Previous 2,781 0.04%

Holding current value

$2.08 Million

Previous $902,000 0.22%

% of portfolio

0.21%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $296 - $337	1 Added 0.04%	2,782 $900,000
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $16,166 - $18,981	-58 Reduced 2.04%	2,781 $902,000
Q1 2022 Apr 07, 2022	SELL	$234.69 - $291.66 $57,499 - $71,456	-245 Reduced 7.94%	2,839 $813,000
Q4 2021 Jan 18, 2022	SELL	$224.85 - $279.04 $22,035 - $27,345	-98 Reduced 3.08%	3,084 $852,000
Q3 2021 Nov 01, 2021	SELL	$221.6 - $272.71 $6,648 - $8,181	-30 Reduced 0.93%	3,182 $735,000
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $75,108 - $97,152	-416 Reduced 11.47%	3,212 $737,000
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $254,696 - $329,716	-1,550 Reduced 29.93%	3,628 $678,000
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $24,004 - $31,763	-184 Reduced 3.43%	5,178 $874,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $59,365 - $68,666	406 Added 8.19%	5,362 $794,000
Q2 2020 Oct 07, 2020	BUY	$136.42 - $164.18 $12,277 - $14,776	90 Added 1.85%	4,956 $814,000
Q1 2020 Oct 07, 2020	SELL	$119.05 - $147.35 $126,907 - $157,075	-1,066 Reduced 17.97%	4,866 $675,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $42,768 - $52,972	-400 Reduced 6.32%	5,932 $780,000
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $12,494 - $13,590	-117 Reduced 1.81%	6,332 $708,000
Q2 2019 Aug 06, 2019	BUY	$110.79 - $129.32 $9,306 - $10,862	84 Added 1.32%	6,449 $715,000
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $21,705 - $25,548	-195 Reduced 2.97%	6,365 $826,000
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $9,319 - $10,440	-88 Reduced 1.32%	6,560 $759,000
Q3 2018 Oct 09, 2018	BUY	$85.86 - $107.31 $1,202 - $1,502	14 Added 0.21%	6,648 $713,000
Q2 2018 Jul 26, 2018	SELL	$75.7 - $86.88 $4,239 - $4,865	-56 Reduced 0.84%	6,634 $566,000
Q1 2018 Apr 10, 2018	BUY	$74.21 - $87.6 $2,894 - $3,416	39 Added 0.59%	6,690 $518,000
Q4 2017 Feb 08, 2018	SELL	$81.94 - $87.89 $3,523 - $3,779	-43 Reduced 0.64%	6,651 $562,000
Q3 2017 Nov 07, 2017	SELL	$77.07 - $85.54 $17,803 - $19,759	-231 Reduced 3.34%	6,694 $573,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,925	6,925 $571,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.

Account